• Home
  • The Potential of Salivary Lipid-Based Cannabis-Responsive Biomarkers to Evaluate Medical Cannabis Treatment in Children with Autism Spectrum Disorder.

The Potential of Salivary Lipid-Based Cannabis-Responsive Biomarkers to Evaluate Medical Cannabis Treatment in Children with Autism Spectrum Disorder.

Author List
Siani-Rose M, McKee R, Cox S, Goldstein B, Abrams D, Taylor M, Kurek I
Publication
Cannabis and cannabinoid research
Publication ID (Profile URL)
https://researcherprofiles.org/profile/276276143
Publication Year
2022
PubMed ID
35343818
Publication Title
Siani-Rose M, McKee R, Cox S, Goldstein B, Abrams D, Taylor M, Kurek I. The Potential of Salivary Lipid-Based Cannabis-Responsive Biomarkers to Evaluate Medical Cannabis Treatment in Children with Autism Spectrum Disorder. Cannabis Cannabinoid Res. 2023 08; 8(4):642-656.